Compare Lustrum:Oncolys BioPharma Inc.:4588

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Oncolys BioPharma Inc. Go to web site 4588 Medicals 東証グロース December 1, 2000 2013.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Oncolys BioPharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Balance Sheet 2024年12月期 Oncolys BioPharma Inc. Balance Sheet 2023年12月期 Oncolys BioPharma Inc. Balance Sheet 2022年12月期 Oncolys BioPharma Inc. Balance Sheet 2021年12月期 Oncolys BioPharma Inc. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents
(Percent)
2,411up
(75.4%)up
1,533down
(75.1%)up
1,711down
(64.6%)down
3,455up
(80.5%)up
2,068
(73.9%)
Other Current AssetsHelp
(Percent)
687up
(21.5%)up
423down
(20.7%)down
897up
(33.9%)up
743up
(17.3%)up
478
(17.1%)
Tangible Fixed AssetsHelp
(Percent)
0
-
0
-
0
-
0
-
21
(0.8%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
1
(0.0%)
Investments and OthersHelp
(Percent)
101up
(3.1%)down
85up
(4.2%)up
42down
(1.6%)down
94down
(2.2%)down
229
(8.2%)
Total AssetsHelp
(Percent)
3,199
(100%)
2,041
(100%)
2,651
(100%)
4,292
(100%)
2,796
(100%)
Total Current LiabilitiesHelp
(Percent)
260down
(8.1%)down
387up
(18.9%)up
329down
(12.4%)up
436up
(10.2%)down
420
(15.0%)
Total Long-term LiabilitiesHelp
(Percent)
187up
(5.8%)down
180up
(8.8%)up
162down
(6.1%)up
262down
(6.1%)down
373
(13.3%)
Shareholder's EquityHelp
(Percent)
2,752up
(86.0%)up
1,474down
(72.2%)down
2,159down
(81.5%)down
3,594up
(83.7%)up
2,003
(71.6%)
Total LiabilitiesHelp
(Percent)
3,199
(100%)
2,041
(100%)
2,651
(100%)
4,292
(100%)
2,796
(100%)

Oncolys BioPharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Profit and Loss Account 2024年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2023年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2022年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2021年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales
(Percent)
31
(100%)
63
(100%)
976
(100%)
642
(100%)
314
(100%)
Total Sales
(Percent)
31
(100%)
63
(100%)
976
(100%)
642
(100%)
314
(100%)
Cost of SalesHelp
(Percent)

-
32down
(51.4%)down
638up
(65.3%)down
444up
(69.1%)up
78
(24.8%)
Other Costs and RevenueHelp 1,716down
(5,468.3%)up
1,969up
(3,123.7%)up
1,487down
(152.4%)down
1,814down
(282.4%)down
2,331
(742.0%)
Total CostsHelp 1,716 2,002 2,125 2,258 2,409
Net RevenueHelp
-
31down
(48.6%)up
338up
(34.7%)up
199down
(30.9%)down
236
(75.2%)
Earnings Before TaxHelp -1,681up
(-5,356.3%)down
-1,936down
(-3,070.5%)down
-1,146up
(-117.4%)up
-1,612up
(-250.9%)up
-2,091
(-665.7%)
Net IncomeHelp -1,685up
(-5,368.3%)down
-1,939down
(-3,075.1%)down
-1,149up
(-117.7%)up
-1,615up
(-251.4%)up
-2,095
(-666.8%)
当期純利益 -1,685 -1,939 -1,149 -1,615 -2,095

Oncolys BioPharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Cash Flow Statement 2024年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2023年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2022年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2021年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-2,020down
(-69.6%)up
-1,337up
(-99.6%)down
-1,717up
(-93.8%)down
-1,742down
(-55.7%)up
-1,465
(-96.6%)
Investing Cash Flow(ICF)Help
(Percent)
-5up
(-0.2%)up
-5down
(-0.4%)down
20up
(1.1%)up
-1up
(0.0%)up
-38
(-2.5%)
Financing Cash FlowHelp
(Percent)
2,879up
(99.2%)up
1,143up
(85.1%)up
-114down
(-6.2%)down
3,091up
(98.8%)up
242
(16.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
24up
(0.8%)down
21down
(1.6%)down
67up
(3.7%)up
38up
(1.2%)up
-14
(-0.9%)
Net Increase and Decrease in Cash and Cash Equivalentsn 878up
(30.3%)up
-178up
(-13.3%)up
-1,743down
(-95.2%)down
1,387up
(44.3%)up
-1,275
(-84.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Oncolys BioPharma Inc.
Pole To Win Holdings, Inc.

Company where related level is highHelp

WAKAMOTO PHARMACEUTICAL CO.,LTD.
Tsubota Laboratory Incorporated
OncoTherapy Science,Inc.
Medrx Co.,Ltd.
CellSource Co., Ltd.
Carna Biosciences,Inc.
AnGes,Inc.
HEALIOS K.K.
DENKA SEIKEN Co.,Ltd.
Solasia Pharma K.K.